Structure-Activity Relationship of 4,6-Disubstituted Pyrimidines as EGFR and VEGFR-2 Tyrosine Kinase Inhibitors

被引：2

作者：

Song, Jiho ^{[1
]}

Lee, Jung Wook ^{[1
]}

Chung, Shin Hyuck ^{[1
]}

Wenas, Michelle A. ^{[1
]}

Min, Kyung Hoon ^{[1
]}

机构：

[1] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea

来源：

BULLETIN OF THE KOREAN CHEMICAL SOCIETY | 2017年 / 38卷 / 11期

基金：

新加坡国家研究基金会;

关键词：

EGFR; VEGFR-2; Tyrosine kinase inhibitors; Pyrimidine; GROWTH-FACTOR RECEPTOR; BEVACIZUMAB; ERLOTINIB; CANCER; RESISTANCE; THERAPY; CELL;

D O I：

10.1002/bkcs.11278

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：1255 / 1256

页数：2

共 50 条

[41] Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors
Hennequin, LF
Thomas, AP
Johnstone, C
Stokes, ESE
Plé, PA
Lohmann, JJM
Ogilvie, DJ
Dukes, M
Wedge, SR
Curwen, JO
Kendrew, J
Lambert-van der Brempt, C
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) : 5369 - 5389
[42] Development and in vivo evaluation of novel inhibitors of the VEGF receptor tyrosine kinase KDR (VEGFR-2)
Bilodeau, MT
Coll, KE
Cunningham, AM
Hartman, GD
Huckle, WR
Hungate, RW
Kendall, RL
Koester, TJ
Rodman, LD
McFall, RC
Mao, XZ
Rutledge, RE
Thomas, KA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : B142 - B142
[43] Structure-activity relationship of C4-substituted pyrimidopyrimidines; Dual KDR/FGFR tyrosine kinase inhibitors.
Rossman, P
Luk, K
Chen, Y
Garafalo, L
Graves, B
Jackson, N
Kabat, M
Konzelmann, F
Liu, JJ
Lukacs, C
McDermott, L
Michoud, C
Portland, L
Roberts, J
Schutt, A
Simcox, M
So, SS
Tamborini, B
Yang, H
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U129 - U129
[44] RING TRANSFORMATIONS OF PYRIMIDINES BY ACTION OF NUCLEOPHILES .4. CONVERSION OF 4,6-DISUBSTITUTED PYRIMIDINES INTO 1,2,4-TRIAZOLES BY ACTION OF HYDRAZINE
VANDERPLAS, HC
JONGEJAN, H
RECUEIL DES TRAVAUX CHIMIQUES DES PAYS-BAS, 1970, 89 (07): : 680 - +
[45] STRUCTURE-ACTIVITY STUDIES OF 4,6-DISUBSTITUTED 2-(MORPHOLINOCARBONYL)FURO[3,2-B]INDOLE DERIVATIVES WITH ANALGESIC AND ANTIINFLAMMATORY ACTIVITIES
KAWASHIMA, Y
AMANUMA, F
SATO, M
OKUYAMA, S
NAKASHIMA, Y
SOTA, K
MORIGUCHI, I
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (11) : 2284 - 2290
[46] Identification of new pyrrolo [2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling
Adel, Mai
Serya, Rabah A. T.
Lasheen, Deena S.
Abouzid, Khaled A. M.
BIOORGANIC CHEMISTRY, 2018, 81 : 612 - 629
[47] Identification and structure-activity relationships of 2,6-disubstituted pyrazines as antituberculosis agents
Sun, Yongmao
Petukhova, Valentina
Giri, Rajan S.
Klein, Larry L.
Song, Yang
Zhang, Nan
Peng, Kuan Wei
Wan, Baojie
Wang, Yuehong
Franzblau, Scott G.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[48] Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review
Metwally, Kamel
Abo-Dya, Nader E.
CURRENT MEDICINAL CHEMISTRY, 2024, 31 (36) : 5918 - 5936
[49] Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2
El-Naggar, Abeer M.
Hassan, A. M. A.
Elkaeed, Eslam B.
Alesawy, Mohamed S.
Al-Karmalawy, Ahmed A.
BIOORGANIC CHEMISTRY, 2022, 123
[50] Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors
Li, Yunqi
Tan, Chunyan
Gao, Chunmei
Zhang, Cunlong
Luan, Xudong
Chen, Xiaowu
Liu, Hongxia
Chen, Yuzong
Jiang, Yuyang
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (15) : 4529 - 4535

← 1 2 3 4 5 →